82-year-old patient with a 10-month evolution of lung mass, clinical case report
Keywords:
primary pulmonary non-Hodgkin's lymphoma, pathology, biopsy
Abstract
A female 82-year patient presents to the clinic without pulmonary symptomology and began with an unspecific pain in the left hypochondrium, where ten month later in this location developed a mass. This mass was biopsied which result was not concluding, but in thorax image multiple nodules and one mass were identified. This lung mass was biopsied and the diagnostic.
Downloads
Download data is not yet available.
References
1. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J. 2002;20(3):750–62.
2. Poletti V, Zinzani P, Tomassetti S, Chilosi M. Lymphoproliferative lung disorders. Prog Respir Res. 2007;36:307–22.
3. Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, et al. Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematol. Haematologica. 2008;93(9):1364–71.
4. NCCN. B-Cell Lymphomas. Natl Compr Cancer Netw [Internet]. 2021;Version 3. Available from: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
5. Kim JH, Lee SH, Park J, Kim HY, Lee S Il, Park JO, et al. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 2004;34(9):510–4.
6. Pasquale F. Primary non-Hodgkin’s lymphoma of the lung. Acta Oncol (Madr). 1999;38(5):655–8.
7. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014;89(3):310–4.
8. Hare SS, Souza CA, Bain G, Seely JM, Gomes MM, Quigley M. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012;85(1015):848–64.
9. Jiang AG, Gao XY, Lu HY. Diagnosis and management of a patient with primary pulmonary diffuse large B-cell lymphoma: A case report and review of the literature. Exp Ther Med. 2014;8(3):797–800.
10. Salles G, De Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: A study from the Lunenburg Lymphoma Biomarker Consortium. Blood. 2011;117(26):7070–8.
11. Neri N, Nambo MJ, Avilés A. Diffuse large B-cell lymphoma primary of lung. Hematology. 2011;16(2):110–2.
12. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048–58.
13. Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for staging and response assessment in lymphoma. Radiology. 2015;276(2):323–38.
14. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015;26(8):1163–72.
15. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The lugano classification. J Clin Oncol. 2014;32(27):3059–67.
2. Poletti V, Zinzani P, Tomassetti S, Chilosi M. Lymphoproliferative lung disorders. Prog Respir Res. 2007;36:307–22.
3. Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, et al. Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematol. Haematologica. 2008;93(9):1364–71.
4. NCCN. B-Cell Lymphomas. Natl Compr Cancer Netw [Internet]. 2021;Version 3. Available from: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
5. Kim JH, Lee SH, Park J, Kim HY, Lee S Il, Park JO, et al. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 2004;34(9):510–4.
6. Pasquale F. Primary non-Hodgkin’s lymphoma of the lung. Acta Oncol (Madr). 1999;38(5):655–8.
7. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014;89(3):310–4.
8. Hare SS, Souza CA, Bain G, Seely JM, Gomes MM, Quigley M. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012;85(1015):848–64.
9. Jiang AG, Gao XY, Lu HY. Diagnosis and management of a patient with primary pulmonary diffuse large B-cell lymphoma: A case report and review of the literature. Exp Ther Med. 2014;8(3):797–800.
10. Salles G, De Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: A study from the Lunenburg Lymphoma Biomarker Consortium. Blood. 2011;117(26):7070–8.
11. Neri N, Nambo MJ, Avilés A. Diffuse large B-cell lymphoma primary of lung. Hematology. 2011;16(2):110–2.
12. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048–58.
13. Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for staging and response assessment in lymphoma. Radiology. 2015;276(2):323–38.
14. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015;26(8):1163–72.
15. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The lugano classification. J Clin Oncol. 2014;32(27):3059–67.
Published
2022-03-28
How to Cite
1.
Fernández Freire M, Fernández A, Pantoja S, Sangoquiza S, Tixi R. 82-year-old patient with a 10-month evolution of lung mass, clinical case report. PFR [Internet]. 2022Mar.28 [cited 2024Nov.21];7(1). Available from: https://practicafamiliarrural.org/index.php/pfr/article/view/198
Section
Casos clínicos y Ejercicios clínico patológicos
Copyright (c) 2022 Rural Family Practice
This work is licensed under a Creative Commons Attribution 4.0 International License.
